295 related articles for article (PubMed ID: 27856779)
1. Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil.
Bitoun S; Bouvry D; Borie R; Mahevas M; Sacre K; Haroche J; Psimaras D; Pottier C; Mathian A; Hie M; Boutin DL; Papo T; Godeau B; Valeyre D; Nunes H; Amoura Z; Cohen Aubart F
Neurology; 2016 Dec; 87(24):2517-2521. PubMed ID: 27856779
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil, azathioprine and methotrexate usage in paediatric anti-NMDAR encephalitis: A systematic literature review.
Nosadini M; Mohammad SS; Toldo I; Sartori S; Dale RC
Eur J Paediatr Neurol; 2019 Jan; 23(1):7-18. PubMed ID: 30318435
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy.
Androdias G; Maillet D; Marignier R; Pinède L; Confavreux C; Broussolle C; Vukusic S; Sève P
Neurology; 2011 Mar; 76(13):1168-72. PubMed ID: 21444902
[TBL] [Abstract][Full Text] [Related]
4. [Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
Wang J; Song X; Zhang W; Tong S; Hou J; Chen L; Lou J; Li H; Ding X; Min B
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):507-10. PubMed ID: 12133492
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of refractory neurosarcoidosis treated with infliximab.
Cohen Aubart F; Bouvry D; Galanaud D; Dehais C; Mathey G; Psimaras D; Haroche J; Pottier C; Hie M; Mathian A; Devilliers H; Nunes H; Valeyre D; Amoura Z
J Neurol; 2017 May; 264(5):891-897. PubMed ID: 28260120
[TBL] [Abstract][Full Text] [Related]
6. [Neurosarcoidosis treated with mycophenolate mofetil: two cases].
Chaussenot A; Bourg V; Chanalet S; Fornari JM; Lebrun C
Rev Neurol (Paris); 2007 Apr; 163(4):471-5. PubMed ID: 17452949
[TBL] [Abstract][Full Text] [Related]
7. MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings.
Piñana JL; Valcárcel D; Fernández-Avilés F; Martino R; Rovira M; Barba P; Martínez C; Brunet S; Sureda A; Carreras E; Sierra J
Bone Marrow Transplant; 2010 Sep; 45(9):1449-56. PubMed ID: 20140024
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil as an alternative treatment in sarcoidosis.
Papiris S; Stagaki E; Papadaki G; Kolilekas L; Korbila I; Apollonatou V; Kallieri M; Gialafos H; Chatziioannou S; Papaioannou AI; Manali ED
Pulm Pharmacol Ther; 2019 Oct; 58():101840. PubMed ID: 31518648
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings.
Neumann F; Graef T; Tapprich C; Vaupel M; Steidl U; Germing U; Fenk R; Hinke A; Haas R; Kobbe G
Bone Marrow Transplant; 2005 Jun; 35(11):1089-93. PubMed ID: 15821769
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
Hamilton BK; Rybicki L; Dean R; Majhail NS; Haddad H; Abounader D; Hanna R; Sobecks R; Duong H; Hill BT; Copelan E; Bolwell B; Kalaycio M
Am J Hematol; 2015 Feb; 90(2):144-8. PubMed ID: 25353395
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
[TBL] [Abstract][Full Text] [Related]
12. The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schönlein purpura nephritis.
Ren P; Han F; Chen L; Xu Y; Wang Y; Chen J
Am J Nephrol; 2012; 36(3):271-7. PubMed ID: 22965140
[TBL] [Abstract][Full Text] [Related]
13. [Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis].
Chartaux E; Joly P
Ann Dermatol Venereol; 2010; 137(8-9):507-13. PubMed ID: 20804893
[TBL] [Abstract][Full Text] [Related]
14. Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases.
Gangaputra SS; Newcomb CW; Joffe MM; Dreger K; Begum H; Artornsombudh P; Pujari SS; Daniel E; Sen HN; Suhler EB; Thorne JE; Bhatt NP; Foster CS; Jabs DA; Nussenblatt RB; Rosenbaum JT; Levy-Clarke GA; Kempen JH;
Am J Ophthalmol; 2019 Dec; 208():68-75. PubMed ID: 31344346
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease.
Caravaca-Fontán F; Díaz-Encarnación MM; Lucientes L; Cavero T; Cabello V; Ariceta G; Quintana LF; Marco H; Barros X; Ramos N; Rodríguez-Mendiola N; Cruz S; Fernández-Juárez G; Rodríguez A; Pérez de José A; Rabasco C; Rodado R; Fernández L; Pérez Gómez V; Ávila AI; Bravo L; Lumbreras J; Allende N; Sanchez de la Nieta MD; Rodríguez E; Olea T; Melgosa M; Huerta A; Miquel R; Mon C; Fraga G; de Lorenzo A; Draibe J; Cano-Megías M; González F; Shabaka A; López-Rubio ME; Fenollosa MÁ; Martín-Penagos L; Da Silva I; Alonso Titos J; Rodríguez de Córdoba S; Goicoechea de Jorge E; Praga M;
Clin J Am Soc Nephrol; 2020 Sep; 15(9):1287-1298. PubMed ID: 32816888
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil in paediatric autoimmune or immune-mediated diseases of the central nervous system: clinical experience and recommendations.
Nosadini M; Gadian J; Lim M; Sartori S; Thomas T; Dale RC
Dev Med Child Neurol; 2019 Apr; 61(4):458-468. PubMed ID: 30221751
[TBL] [Abstract][Full Text] [Related]
17. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
Ogarek I; Szczęsny-Choruz E; Wierzchowska-Słowiaczek E; Kwinta-Rybicka J; Stec Z; Moczulska A; Wilkosz K; Drożdż D
Pol Merkur Lekarski; 2018 Apr; 44(262):192-195. PubMed ID: 29775447
[TBL] [Abstract][Full Text] [Related]
18. Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to Methotrexate.
Mertens JS; Marsman D; van de Kerkhof PC; Hoppenreijs EP; Knaapen HK; Radstake TR; de Jong EM; Seyger MM
Acta Derm Venereol; 2016 May; 96(4):510-3. PubMed ID: 26582717
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.
Martini G; Saggioro L; Culpo R; Vittadello F; Meneghel A; Zulian F
Rheumatology (Oxford); 2021 Mar; 60(3):1387-1391. PubMed ID: 32978631
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
Akhyani M; Chams-Davatchi C; Hemami MR; Fateh S
J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]